{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:12:38Z","timestamp":1789776758751,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2012-2","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T11:20:38Z","timestamp":1523445638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review"],"prefix":"10.1186","volume":"22","author":[{"given":"Antoine","family":"N\u00e9el","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-6230","authenticated-orcid":false,"given":"Ana\u00efs","family":"Wahbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Tessoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Decaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Fardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Geri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Godmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Goujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pouchot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Ziza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Bretonni\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"2012_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/ard.54.7.587","volume":"54","author":"G Magadur-Joly","year":"1995","unstructured":"Magadur-Joly G, Billaud E, Barrier JH, et al. Epidemiology of adult Still\u2019s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis. 1995;54:587\u201390.","journal-title":"Ann Rheum Dis."},{"key":"2012_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, S\u00e8ve P. Adult-onset Still\u2019s disease. Autoimmun Rev. 2014;13:708\u201322. \n                    doi.org\/10.1016\/j.autrev.2014.01.058","journal-title":"Autoimmun Rev"},{"key":"2012_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0000000000000021","volume":"93","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore). 2014;93:91\u20139. \n                    doi.org\/10.1097\/MD.0000000000000021","journal-title":"Medicine (Baltimore)"},{"key":"2012_CR4","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/art.27532","volume":"62","author":"S Franchini","year":"2010","unstructured":"Franchini S, Dagna L, Salvo F, et al. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still\u2019s disease. Arthritis Rheum. 2010;62:2530\u20135. \n                    doi.org\/10.1002\/art.27532","journal-title":"Arthritis Rheum"},{"key":"2012_CR5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/S0755-4982(05)84239-3","volume":"34","author":"M Hamidou","year":"2005","unstructured":"Hamidou M, Boutoille D, Masseau A, et al. Adult-onset Still disease with hemophagocytic syndrome treated with cyclosporine. Presse Med. 2005;34:1634\u20136.","journal-title":"Presse Med."},{"key":"2012_CR6","first-page":"373","volume":"26","author":"B Fautrel","year":"1999","unstructured":"Fautrel B, Borget C, Rozenberg S, et al. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still\u2019s disease. J Rheumatol. 1999;26:373\u20138.","journal-title":"J Rheumatol."},{"key":"2012_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.berh.2012.07.002","volume":"26","author":"J Pouchot","year":"2012","unstructured":"Pouchot J, Arlet J-B. Biological treatment in adult-onset Still\u2019s disease. Best Pract Res Clin Rheumatol. 2012;26:477\u201387. \n                    doi.org\/10.1016\/j.berh.2012.07.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2012_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/art.10231","volume":"46","author":"ME Husni","year":"2002","unstructured":"Husni ME, Maier AL, Mease PJ, et al. Etanercept in the treatment of adult patients with Still\u2019s disease. Arthritis Rheum. 2002;46:1171\u20136. \n                    doi.org\/10.1002\/art.10231","journal-title":"Arthritis Rheum"},{"key":"2012_CR9","first-page":"329","volume":"19","author":"L Cavagna","year":"2001","unstructured":"Cavagna L, Caporali R, Epis O, et al. Infliximab in the treatment of adult Still\u2019s disease refractory to conventional therapy. Clin Exp Rheumatol. 2001;19:329\u201332.","journal-title":"Clin Exp Rheumatol."},{"key":"2012_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/ard.2004.024026","volume":"64","author":"B Fautrel","year":"2005","unstructured":"Fautrel B, Sibilia J, Mariette X, et al. Tumour necrosis factor alpha blocking agents in refractory adult Still\u2019s disease: an observational study of 20 cases. Ann Rheum Dis. 2005;64:262\u20136. \n                    doi.org\/10.1136\/ard.2004.024026","journal-title":"Ann Rheum Dis"},{"key":"2012_CR11","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/art.21061","volume":"52","author":"AA Fitzgerald","year":"2005","unstructured":"Fitzgerald AA, Leclercq SA, Yan A, et al. Rapid responses to anakinra in patients with refractory adult-onset Still\u2019s disease. Arthritis Rheum. 2005;52:1794\u2013803. \n                    doi.org\/10.1002\/art.21061","journal-title":"Arthritis Rheum"},{"key":"2012_CR12","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/ar3366","volume":"13","author":"K Laskari","year":"2011","unstructured":"Laskari K, Tzioufas AG, Moutsopoulos HM, et al. Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still\u2019s disease: a case-series study. Arthritis Res Ther. 2011;13:R91. \n                    doi.org\/10.1186\/ar3366","journal-title":"Arthritis Res Ther"},{"key":"2012_CR13","doi-asserted-by":"publisher","first-page":"e1554","DOI":"10.1097\/MD.0000000000001554","volume":"94","author":"F Ortiz-Sanju\u00e1n","year":"2015","unstructured":"Ortiz-Sanju\u00e1n F, Blanco R, Riancho-Zarrabeitia L, et al. Efficacy of anakinra in refractory adult-onset Still\u2019s disease: multicenter study of 41 patients and literature review. Medicine (Baltimore). 2015;94:e1554. \n                    doi.org\/10.1097\/MD.0000000000001554","journal-title":"Medicine (Baltimore)"},{"key":"2012_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/acr.20319","volume":"63","author":"X Pu\u00e9chal","year":"2011","unstructured":"Pu\u00e9chal X, DeBandt M, Berthelot JM, et al. Tocilizumab in refractory adult Still's disease. Arthritis Care Res. 2011;63:155\u20139. \n                    doi.org\/10.1002\/acr.20319","journal-title":"Arthritis Care Res"},{"key":"2012_CR15","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/art.38398","volume":"66","author":"F Ortiz-Sanju\u00e1n","year":"2014","unstructured":"Ortiz-Sanju\u00e1n F, Blanco R, Calvo-Rio V, et al. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still\u2019s disease: multicenter retrospective open-label study of thirty-four patients. Arthritis Rheumatol. 2014;66:1659\u201365. \n                    doi.org\/10.1002\/art.38398","journal-title":"Arthritis Rheumatol"},{"key":"2012_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","volume":"33","author":"P Efthimiou","year":"2014","unstructured":"Efthimiou P, Kadavath S, Mehta B. Life-threatening complications of adult-onset Still\u2019s disease. Clin Rheumatol. 2014;33:305\u201314. \n                    doi.org\/10.1007\/s10067-014-2487-4","journal-title":"Clin Rheumatol"},{"key":"2012_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","volume":"89","author":"A Hot","year":"2010","unstructured":"Hot A, Toh M-L, Copp\u00e9r\u00e9 B, et al. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Medicine (Baltimore). 2010;89:37\u201346. \n                    doi.org\/10.1097\/MD.0b013e3181caf100","journal-title":"Medicine (Baltimore)"},{"key":"2012_CR18","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1097\/MD.0000000000000451","volume":"94","author":"C-B Bae","year":"2015","unstructured":"Bae C-B, Jung J-Y, Kim H-A, Suh C-H. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore). 2015;94:e451. \n                    doi.org\/10.1097\/MD.0000000000000451","journal-title":"Medicine (Baltimore)"},{"key":"2012_CR19","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1136\/ard.2005.046904","volume":"65","author":"J-B Arlet","year":"2006","unstructured":"Arlet J-B, Le THD, Marinho A, et al. Reactive haemophagocytic syndrome in adult-onset Still\u2019s disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006;65:1596\u2013601. \n                    doi.org\/10.1136\/ard.2005.046904","journal-title":"Ann Rheum Dis"},{"key":"2012_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/MD.0000000000000112","volume":"93","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, S\u00e8ve P, Iwaz J, et al. Myocarditis in adult-onset still disease. Medicine (Baltimore). 2014;93:280\u20139. \n                    doi.org\/10.1097\/MD.0000000000000112","journal-title":"Medicine (Baltimore)"},{"key":"2012_CR21","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19:424\u201330.","journal-title":"J Rheumatol."},{"key":"2012_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","volume":"81","author":"B Fautrel","year":"2002","unstructured":"Fautrel B, Zing E, Golmard J-L, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81:194\u2013200.","journal-title":"Medicine (Baltimore)."},{"key":"2012_CR23","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"J-R Le Gall","year":"1993","unstructured":"Le Gall J-R, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study. JAMA. 1993;270:2957\u201363.","journal-title":"JAMA."},{"key":"2012_CR24","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jama.1996.03540100046027","volume":"276","author":"JR Le Gall","year":"1996","unstructured":"Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA. 1996;276:802\u201310.","journal-title":"JAMA."},{"key":"2012_CR25","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818\u201329.","journal-title":"Crit Care Med."},{"key":"2012_CR26","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al. Development and validation of a score for the diagnosis of reactive hemophagocytic syndrome (HScore). Arthritis Rheumatol. 2014;66:2613\u201320. \n                    doi.org\/10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"2012_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3899\/jrheum.161286","volume":"44","author":"SS Ahn","year":"2017","unstructured":"Ahn SS, Yoo B-W, Jung SM, et al. Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease. J Rheumatol. 2017;44:996\u20131003. \n                    doi.org\/10.3899\/jrheum.161286","journal-title":"J Rheumatol"},{"key":"2012_CR28","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","volume":"106","author":"K Mazodier","year":"2005","unstructured":"Mazodier K, Marin V, Novick D, et al. Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome. Blood. 2005;106:3483\u20139. \n                    doi.org\/10.1182\/blood-2005-05-1980","journal-title":"Blood"},{"key":"2012_CR29","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/ard.2003.016428","volume":"63","author":"T Rooney","year":"2004","unstructured":"Rooney T, Murphy E, Benito M, et al. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann Rheum Dis. 2004;63:1393\u20138. \n                    doi.org\/10.1136\/ard.2003.016428","journal-title":"Ann Rheum Dis"},{"key":"2012_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/ard.2008.093781","volume":"68","author":"P Conigliaro","year":"2009","unstructured":"Conigliaro P, Priori R, Bombardieri M, et al. Lymph node IL-18 expression in adult-onset Still\u2019s disease. Ann Rheum Dis. 2009;68:442\u20133. \n                    doi.org\/10.1136\/ard.2008.093781","journal-title":"Ann Rheum Dis"},{"key":"2012_CR31","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I","volume":"44","author":"Y Kawaguchi","year":"2001","unstructured":"Kawaguchi Y, Terajima H, Harigai M, et al. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still\u2019s disease. Arthritis Rheum. 2001;44:1716\u20137. \n                    doi.org\/10.1002\/1529-0131","journal-title":"Arthritis Rheum"},{"key":"2012_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00134-008-1111-y","volume":"34","author":"C Creput","year":"2008","unstructured":"Creput C, Galicier L, Buyse S, et al. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 2008;34:1177\u201387. \n                    doi.org\/10.1007\/s00134-008-1111-y","journal-title":"Intensive Care Med"},{"key":"2012_CR33","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3899\/jrheum.100247","volume":"37","author":"M Rau","year":"2010","unstructured":"Rau M, Schiller M, Krienke S, et al. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis. J Rheumatol. 2010;37:2369\u20137. \n                    doi.org\/10.3899\/jrheum.100247","journal-title":"J Rheumatol"},{"key":"2012_CR34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","volume":"25","author":"SM Opal","year":"1997","unstructured":"Opal SM, Fisher CJ Jr, Dhainaut JF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997;25:1115\u201324.","journal-title":"Crit Care Med."},{"key":"2012_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44:275\u201381. \n                    doi.org\/10.1097\/CCM.0000000000001402","journal-title":"Crit Care Med"},{"key":"2012_CR36","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s10067-010-1459-6","volume":"29","author":"G Moulis","year":"2010","unstructured":"Moulis G, Sailler L, Astudillo L, et al. May anakinra be used earlier in adult onset Still disease? Clin Rheumatol. 2010;29:1199\u2013200. \n                    doi.org\/10.1007\/s10067-010-1459-6","journal-title":"Clin Rheumatol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2012-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T19:07:09Z","timestamp":1554923229000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2012-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2012-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This observational study was performed in accordance with the Helsinki declaration, European and French ethical laws.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"88"}}